“He is now receiving an investigational medication, brincidofovir, for Ebola Virus Disease,” hospital spokeswoman Candace White said in a tweet.
The announcement that he is now being treated with an experimental anti-viral medication called brincidofovir comes the same day that the Food and Drug Administration approved its use in experimental cases.
Brincidofovir is produced by Chimerix, a Durham, North Carolina-based company and was approved through an Emergency Investigational New Drug Applications program by the FDA.